Comparable stake leader
League Jinn Sarl
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001783036.
Comparable stake leader
League Jinn Sarl
Disclosed value leader
League Jinn Sarl
Comparable rows
11/12
Latest evidence
27 Apr 2026
Ownership snapshot
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Quick read
11 of 12 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| League Jinn Sarl |
13D/G
|
25%
|
$3,303,830
1,316,267 shares
|
+$821,450 | 27 Apr 2026 |
| Michel Revel |
3/4/5
13D/G
CSO and Director, Director, 10%+ Owner
|
20%
from 13D/G
|
$2,633,207
1,033,893 shares
mixed-class rows
|
+$149,999 | 27 Apr 2026 |
| Ronald Hafner |
13D/G
|
13%
|
—
557,131 shares
|
$0 | 22 May 2025 |
| CLOVER WOLF CAPITAL - LIMITED PARTNERSHIP |
13D/G
|
7.5%
|
—
343,120 shares
|
$0 | 30 Oct 2025 |
| Ronen Twito |
3/4/5
13D/G
Chairman and CEO, Director
|
6%
from 13D/G
|
$781,785
272,399 shares
|
— | 18 Mar 2026 |
| Lind Global Fund II LP |
13D/G
|
4.9%
|
$90,866
59,780 shares
|
$0 | 31 Dec 2024 |
| BIOTECHNOLOGY VALUE FUND L P |
13D/G
BVF PARTNERS L P/IL
|
0.6%
|
—
28,732 shares
|
$0 | 31 Oct 2025 |
| UBS Group AG |
13F
Company
|
0.01%
|
$1,450
684 shares
|
— | 31 Mar 2026 |
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Net insider flow leans to buying over the last 12 months. Net value: +$374,998.
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 136,363 | 0 | $374,998 | $0 | +$374,998 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Showing 1-9 of 9 reporting-owner rows connected to NewcelX Ltd.. Open a relationship link for the CIK-to-CIK filing trail.
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Michel Revel | CSO and Director, Director, 10%+ Owner | $2,633,207 | +$149,999 | +6% | Filing P/S | 27 Apr 2026 |
| Ronen Twito | Chairman and CEO, Director | $781,785 | Mixed | 18 Mar 2026 | ||
| Olivier Samuel | Director | $224,999 | +$225,000 | +100% | Filing P/S | 27 Apr 2026 |
| Eran Israel Iohan | Director | Mixed | 18 Mar 2026 | |||
| Liora Oren | Director | Mixed | 18 Mar 2026 | |||
| Omri Hagai | Chief Financial Officer | Mixed | 18 Mar 2026 | |||
| Alexander Zwyer | Director | Mixed | 18 Mar 2026 | |||
| Kfir Molakandov | VP of R&D | Mixed | 18 Mar 2026 | |||
| Tamar Galili | Director | Mixed | 18 Mar 2026 |
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Olivier Samuel | NCEL | Common Shares, par value CHF 0.05 per share | Purchase | $225,000 | $2.75 | 81,818 | 81,818 | 27 Apr 2026 | Direct | |
| Olivier Samuel | NCEL | Warrant (right to buy) | Purchase | 114,545 | 114,545 | 27 Apr 2026 | Direct | |||
| Michel Revel | NCEL | Common Shares, par value CHF 0.05 per share | Purchase | 6.04% | $149,999 | $2.75 | 54,545 | 957,530 | 27 Apr 2026 | Direct |
| Michel Revel | NCEL | Warrant (right to buy) | Purchase | 76,363 | 76,363 | 27 Apr 2026 | Direct |